SMAD4 and cholangiocarcinoma: Loss of SMAD4 activity is a common characteristic of gastrointestinal tumors and is most frequently observed in CCA originating in the distal common bile duct, near the pancreas—where SMAD4 mutations are particularly prevalent [163].